Boy taking photo with old camera

I AM
FOCUSED ON
MY PASSION

I AM MORE THAN MY ADHD

Your support

Here you can get a number of useful materials that will help you and your child through the process of switching medicines and living life with ADHD.

Measurement tracker

Monitor your child’s growth and development to help plan treatment holidays

Download

Weekly mood diary

Spot patterns in your child’s mood and behaviour to help make positive changes

Download

Relaxation exercises

Simple exercises to help spread calm every day

Download

Further information about Xenidate XL

Your child’s medicine package will contain a patient information leaflet relevant to their dose but you can also view and download copies of the leaflets below.

Viatris

If you get any side effects or have a device failure, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. Please report side effects or device failures with any medicine or vaccine to the medicines regulator MHRA through the Yellow Card Scheme.
It is easiest and quickest to report side effects and device failures online via the Yellow Card website:  https://yellowcard.mhra.gov.uk/ or search for MHRA Yellow Card in the Google Play or Apple App Store.
Alternatively, prepaid Yellow Cards for reporting are available by writing to FREEPOST YELLOW CARD (no other address details necessary), by emailing yellowcard@mhra.gov.uk, by telephoning the Commission on Human Medicines (CHM) free phone line: 0800-731-6789, or by downloading and printing a form from the Yellow Card section of the MHRA website. You can also report side effects and device failures direct to the marketing authorisation holder at pv.uk@viatris.com.

| Contact us | Privacy policy | T&Cs | Data Protection | Sitemap

Copyright © 2022 Viatris Inc. All rights reserved.
The content on this site is intended for use with UK members of the public only.
Concerta XL® is a registered trademark of Janssen-Cilag Ltd
This website is owned and managed by Viatris

Please note, while efforts have been made to choose reputable sources, Viatris cannot take responsibility on these pages maintained by external providers.
We recommend that you read the full patient information leaftlet leaflet carefully before using Xenidate XL

Xenidate XL Indication: As part of a comprehensive treatment programme for Attention Deficit/Hyperactivity Disorder (ADHD) in children aged 6 years and over and adolescents when remedial measures alone prove insufficient. Treatment must be under the supervision of a specialist in childhood behavioural disorders

MET-2021-0013
Date of Preparation: June 2022.

Viatris UK Healthcare Limited (company registration number 09189103), an English company with a registered office address at 20 Station Close, Potters Bar, Hertfordshire, EN6 1TL (VAT - 421 623 781)